Product Images Augmentin

This text provides directions for mixing and dosage information for AUGMENTIN oral suspension, a medication containing amoxicillin and clavulanate potassium. The text explains how much water to mix with the powder and emphasizes shaking the bottle vigorously. The medication should be refrigerated after reconstitution and discarded after 10 days. The NDC number and net contents are also provided. The medication should only be used if the inner seal is intact. The text includes manufacturing and storage information.*

This is a set of directions for mixing a medication with the NDC code of 28595-240-36. The medication is Augmentin and is in powder form. It is to be mixed with 134 mL of water to create an oral suspension. After mixing, each 5 mL of the suspension will contain 125 mg of Amoxicillin and 31.25 mg of Clavulanic Acid. The suspension should be kept refrigerated and discarded after 10 days. There may be some color change during the dosing period.*

This text provides instructions for dosing of amoxicillin and clavulanate potassium for treating infections such as otitis media, sinusitis, and lower respiratory tract infections. The recommended dosing regimen differs for less severe and more severe infections, with the latter requiring higher doses every 8 or 12 hours. The duration of therapy studied and recommended for acute otitis media is 10 days. Additionally, chewable tablets are available for the oral suspension for use by older children.*

This text provides information on the dosage and regimen of Amoxicillin and Clavulanate, with data on C max and AUC. It shows the values obtained for different doses and frequencies, as well as the time required for concentrations to occur. The administration of Amoxicillin and Clavulanate is recommended at the start of a light meal. The data was obtained from a study of 14 normal adults.*

This text provides pharmacokinetic data regarding the administration of Amoxicillin and Clavulanate potassium to 28 normal adults. The data includes the maximum concentration (C max) and area under the concentration-time curve (AUC) for two different forms of the medication: a 1400mg/57mg suspension and a 1400mg/57mg chewable tablet. The medication was administered at the start of a light meal and peak concentrations were observed around 1 hour after dosing.*